The Future of Drug Design: How Machine Learning is Revolutionizing PROTAC Development
As the fight against disease has changed, so have therapeutic strategies. One such new approach is Targeted Protein Degradation (TPD), which attempts to exploit the cell’s natural degradation machinery to get rid of unnecessary proteins. The cornerstone of TPD is PROTACs (Proteolysis-Targeting Chimeras); these molecules are very complex and act like Trojan horses that bring…


















































